nonprofit logo

Dana-Farber Cancer Institute Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 042263040 ✦ Boston, MA ✦ Designated as a 501(c)(3)

Overview

What is Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute Inc, based on the provided information, is a dedicated nonprofit organization focused on delivering specialized, caring cancer treatment to both children and adults. Committed to making strides in the field, they also actively advance research to broaden the knowledge of various cancer types and related diseases, with the ultimate goal of finding cures and preventing their occurrence. The organization is deeply rooted in providing expert care, marked by compassion and dedication to support individuals during their cancer journey.


Official website here: www.dana-farber.org

Is Dana-Farber Cancer Institute Inc legitimate?

Dana-Farber Cancer Institute Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Dana-Farber Cancer Institute Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $11,054,329
Professional Fundraising Fees: $3,929,270
Other Salaries and Wages: $636,395,164

For more financial information, click here


Official website here: www.dana-farber.org

What is the mission statement of Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute is dedicated to delivering specialized care to children and adults diagnosed with cancer. Their mission extends beyond providing compassionate care, as they also strive to expand the knowledge and find cures for various types of cancer and related diseases. By combining their expertise and commitment, Dana-Farber Cancer Institute aims to make advancements in cancer treatment, understanding, and prevention. Their ultimate goal is to create a world where cancer no longer poses a threat.


Official website here: www.dana-farber.org

What is the revenue of Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute Inc's revenue in 2022 was $2,669,084,593.


Official website here: www.dana-farber.org

Who are the executives of Dana-Farber Cancer Institute Inc and what are their salaries?

The average compensation at Dana-Farber Cancer Institute Inc during 2022 was $80,951. There are 7,998 employees and 500 volunteers at Dana-Farber Cancer Institute Inc.

Here are 94 key members and their salaries (Dana-Farber Cancer Institute Inc's CEO's salary is $513,026 and their total compensation is $564,467):

    Laurie H Glimcher Md (Trustee, President, And Ceo)
  • Compensation: $3,672,655
  • Related: $0
  • Other: $321,403

    • Edward J Benz Jr Md (President Ceo Emeritus)
  • Compensation: $2,163,654
  • Related: $0
  • Other: $51,485

    • Matthew Meyerson Md (Professor)
  • Compensation: $903,547
  • Related: $0
  • Other: $69,876

    • William Hahn Md Phd (Coo Evp)
  • Compensation: $855,136
  • Related: $0
  • Other: $37,402

    • Michael L Reney (Cfo Assistant Treasurer)
  • Compensation: $835,469
  • Related: $0
  • Other: $37,481

    • Richard S Boskey Esq (Former Officer)
  • Compensation: $799,400
  • Related: $0
  • Other: $51,348

    • Eric Winer Md (Chief Of Div. Of Women'S Cancers)
  • Compensation: $797,539
  • Related: $0
  • Other: $47,595

    • Michael Constantine Md (Milford Medical Dir. - Hematol Onc.)
  • Compensation: $758,741
  • Related: $0
  • Other: $58,121

    • Craig A Bunnell Md (Chief Medical Officer)
  • Compensation: $762,033
  • Related: $0
  • Other: $40,568

    • Melany Duval (Svp Of Development)
  • Compensation: $725,483
  • Related: $0
  • Other: $51,770

    • Robert Soiffer Md (Chief Of Hemotologic Malignancies)
  • Compensation: $712,796
  • Related: $0
  • Other: $54,177

    • James D Griffin Md (Professor Of Medicine)
  • Compensation: $681,419
  • Related: $0
  • Other: $59,640

    • Bruce Johnson Md (Senior Advisor To President Ceo)
  • Compensation: $671,141
  • Related: $0
  • Other: $56,584

    • John Ryan Esq (Asst. Sec. Gen. Cnsl. (End 1/14/22))
  • Compensation: $617,744
  • Related: $0
  • Other: $31,945

    • Kevin Haigis (Chief Scientific Officer)
  • Compensation: $524,839
  • Related: $0
  • Other: $58,480

    • Maria Megdal (Svp Of Institue Operations)
  • Compensation: $518,918
  • Related: $0
  • Other: $52,529

    • Barrett J Rollins Md Phd (Sr. Advisor President Ceo)
  • Compensation: $513,026
  • Related: $0
  • Other: $51,441

    • Jeffrey Meyerhardt Md Phd (Chief Clinical Research Officer)
  • Compensation: $488,567
  • Related: $0
  • Other: $70,862

    • Elizabeth Liebow (Chief Integration Officer)
  • Compensation: $458,662
  • Related: $0
  • Other: $54,674

    • Wendy Gettleman (Vp Of Facilities Management Real Estate)
  • Compensation: $347,799
  • Related: $0
  • Other: $69,288

    • Sylvia A Bartel Rph Mhp (Vp Of Pharmacy Services)
  • Compensation: $321,990
  • Related: $0
  • Other: $65,749

    • James Terwilliger (Former Officer)
  • Compensation: $360,500
  • Related: $0
  • Other: $0

    • Drew Memmott (Former Key Employee)
  • Compensation: $301,819
  • Related: $0
  • Other: $39,066

    • Benjamin Ebert Md Phd (Chair Of Medical Oncology)
  • Compensation: $199,529
  • Related: $0
  • Other: $8,869

    • John J O'Connor (Trustee Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Joshua Bekenstein (Trustee Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Monica Chandra (Trustee Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Richard Lubin (Trustee Vice-Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Afsaneh Beschloss (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Alison Jaffe (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Amy Berylson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Amy Kyle Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrew Janower (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrew Kaplan (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Beth Terrana (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Betty Ann Blum (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Bradley Lucas (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Brian Knez (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Christopher Hadley (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Demond Martin (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Doug Grip (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Eric Miller (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Eric Schlager (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Esta Stecher (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Fatima Penrose (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Frederica Williams (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Harvey Berger Md (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Hise Gibson (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • James Mccann (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jane Brock-Wilson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jane Jamieson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jennifer Perini (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jessica Knez (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jill Greenthal (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jodi Walker (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jose Aguerrevere (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Joseph Norberg (Trustee (End 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Karen Daley Phd Mph Rn Fann (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Karen Linde Packman (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kate Gulliver (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kevin Dasilva (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kimberly Sherman Stamler (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Laura Sen (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lisa Ferraro (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lori Whelan (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Louise Svanberg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mary Ann Tocio (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Meg Reynolds (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael Eisenson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael Trotsky (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Moria Forbes (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Nancy Gibson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Nancy Lotane (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Paul Marcus (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Peter Palandjian (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Phillip Gross (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Reynolds (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Sachs (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Robert Stansky (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Roger Berkowitz (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Roger Medel (Trustee (End 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Ronald Sullivan (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sandra Stratford Md (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Stephen Fine (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Stephen Koster Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Steven Koppel (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Susan Alexander Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Susan Poduska (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sushil Tuli (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Theodore Pasquarello (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Timothy Cohen (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Tracey Mccain Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jennifer Willcox Esq (Asst. Sec. Gc (Begin 6/1/22))
  • Compensation: $0
  • Related: $0
  • Other: $0

    • John O Chesley Esq (Asst. Sec. Gc (Begin 1/14/22))
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.dana-farber.org

    Where can I find the form 990 for Dana-Farber Cancer Institute Inc?

    The Dana-Farber Cancer Institute Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.dana-farber.org

    Learn more at the official website: www.dana-farber.org

    Mission Statement of Dana-Farber Cancer Institute Inc

    Dana-Farber Cancer Institute, a renowned institution, is dedicated to making a significant impact on the lives of children and adults diagnosed with cancer. With a deep-rooted commitment to delivering expert and compassionate care, the institute is not only focused on alleviating the physical symptoms but also on providing emotional support throughout the entire treatment process.

    Beyond its clinical efforts, Dana-Farber Cancer Institute is an unequivocal leader in the scientific community, relentlessly pursuing advancements in the understanding, treatment, cure, and prevention of cancer and related diseases. The institute's unwavering mission is to transform the landscape of cancer care and ultimately, save lives.

    By bringing together world-renowned researchers, clinicians, and scientists, Dana-Farber Cancer Institute fosters a collaborative and interdisciplinary environment where bold discoveries are made and translated into innovative therapies. The ultimate goal is to improve patient outcomes and pave the way for a cancer-free future.

    Impact

    This information is meant to be a general summary of Dana-Farber Cancer Institute Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    Dana-Farber Cancer Institute Inc is committed to providing expert, compassionate care to children and adults with cancer while advancing the understanding, treatment, cure, and prevention of cancer and related diseases. Through its dedication to medical research and patient care, Dana-Farber Cancer Institute Inc has a significant impact on the fight against cancer, improving the lives of countless individuals and families affected by this disease.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $928,841
  • Program Service Revenue: $1,911,183,785
  • Gross Receipts: $2,672,062,824

    • Assets and Liabilities:
  • Total Assets: $4,291,020,227
  • Total Liabilities: $1,487,687,279
  • Net Assets: $2,803,332,948
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    NET PATIENT SERVICE REVENUE

    Revenue

    $1,896,457,895

    NETWORK COLLABORATION

    Revenue

    $12,022,552

    LINAC

    Revenue

    $2,703,338

    Organization Details

    Founding Year

    1951

    Main Address

    450 BROOKLINE AVENUE BP418, BOSTON, MA, 02215

    NTEE Category

    Code: G30 - Disease

    If you are a representative of Dana-Farber Cancer Institute Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.